What cells express CD200?
What cells express CD200?
CD200 is a type I transmembrane glycoprotein belonging to the immunoglobulin superfamily, and is expressed by a variety of cells, including B cells, activated T cells, follicular dendritic cells (DCs), and neurons [11–13].
What is CD200 marker?
CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry. Int J Lab Hematol.
What does CD23 positive mean?
CD23 antigen is a cell surface protein considered important in the differentiation of chronic lymphocytic leukemia (CLL) from other lymphoid leukemias.
What are CD23 cells?
2.1. CD23 is an integral membrane glycoprotein involved in the regulation of IgE synthesis. It is expressed by subsets of B cells, monocytes, follicular dendritic cells, platelets, and eosinophils.
Is CD20 on T cells?
The display of CD20 on a subset of T cells is not due to doublets between B and T cells, because these cells display a lower level of CD20 than B cells and lack markers typically found on B cells such as HLA-DR, CD40 (Fig. 1), and CD19.
Does Rituxan lower your immune system?
Rituximab suppresses the immune system. Therefore, serious fungal, bacterial, and new or reactivated viral infections (for example, hepatitis B or C, shingles) can occur during or after treatment with rituximab.
How is CD200 expressed in B-CLL cells?
Although these data cannot be generalized, all B-CLL samples we examined were positive, with CD200 present on the vast majority of the cells while, in MCL patients, CD200 was expressed by a small minority of CD5+ cells in three subjects and totally absent in the remaining 11.
Are there CD200 + cells in the lymph nodes?
Again, all B-CLL cells were CD200+ both in lymph nodes and in BM while all MCL cells were negative. Adding CD200 in routine panels could be of diagnostic utility in excluding MCL diagnosis.
How many cases of McL are negative for CD200?
The remaining 42 cases (91.3%) of MCL were negative for CD200 expression. The revised Matutes score was calculated to classify CLL cases. All 179 cases of typical CLL (defined by a score ≥ 4) presented moderate to strong expression of CD200 (Median fluorescence intensity – MFI: median = 161).
Are there any clinical trials for CD200 Ko?
There are currently no active adult or pediatric cancer clinical trials examining or targeting CD200. CD200 KO mice are more susceptible to infection with Neisseria meningitidis than WT mice.